Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Fr | Esperion Therapeutics, Inc.: Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | 50 | GlobeNewswire (Europe) | ANN ARBOR, Mich., May 10, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that on May 8, 2024, the Company granted 16 new employees 62,300 restricted stock units (RSUs) under Esperion's... ► Artikel lesen | |
Mi | Esperion (ESPR) Q1 Earnings Beat, Stock Up on Strong Revenues | 8 | Zacks | ||
Di | Earnings call: Esperion reveals robust Q1 growth, FDA approval boosts | 7 | Investing.com | ||
Di | Heart Disease Drugmaker Esperion Therapeutics Reports Highest Revenue Yet, Stock Soars | 3 | Benzinga.com | ||
Di | Esperion Therapeutics Inc reports results for the quarter ended in March - Earnings Summary | 3 | Reuters | ||
Di | Esperion Therapeutics, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
Di | Why Is Esperion Therapeutics (ESPR) Stock Up 13% Today? | 9 | InvestorPlace | ||
Di | Pre-market Movers: reAlpha Tech, GreenPower Motor, Esperion Therapeutics, FibroGen, Holdco Nuvo Group D.G | 333 | AFX News | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 07.40 A.M. ET).In the Green reAlpha Tech Corp. (AIRE) is up over 50% at $1.29.
Esperion... ► Artikel lesen | |
Di | Esperion Therapeutics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
Di | Esperion Soars on Q1 Earnings Beat, Revenue Surge | 10 | Investing.com | ||
Di | Esperion Therapeutics beats top-line and bottom-line estimates; reaffirms FY24 outlook | 9 | Seeking Alpha | ||
Di | Esperion Therapeutics, Inc.: Esperion Reports First Quarter 2024 Financial Results | 64 | GlobeNewswire (Europe) | - Q1 Total Revenue Grew 467% Y/Y to $137.7 Million, Reflecting Strong Growth Globally - - Q1 U.S. Net Product Revenue Grew 46% Y/Y to $24.8 Million - - Q1 Retail Prescription Equivalents Grew 43%... ► Artikel lesen | |
06.05. | Esperion Therapeutics Q1 2024 Earnings Preview | 5 | Seeking Alpha | ||
29.04. | Esperion Therapeutics, Inc.: Esperion to Participate in Upcoming May Investor Conferences | 5 | GlobeNewswire (USA) | ||
08.04. | Esperion stock jumps as non-statin therapy shows clinical benefits across diverse patient groups | 15 | Seeking Alpha | ||
08.04. | Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket | 7 | Benzinga.com | ||
07.04. | Esperion Therapeutics, Inc.: Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity | 126 | GlobeNewswire (Europe) | - Patients With Obesity Who Took NEXLETOL Were 23% Less Likely to Experience a Major Adverse Cardiovascular Event (MACE-4) Compared to Placebo - - NEXLETOL Demonstrated Clinical Benefit in Historically... ► Artikel lesen | |
01.04. | Esperion Therapeutics, Inc.: Esperion to Ring Nasdaq Opening Bell Today, April 1, 2024 | 7 | GlobeNewswire (USA) | ||
26.03. | Esperion Therapeutics, Inc.: Esperion to Participate in 23rd Annual Needham Virtual Healthcare Conference | 6 | GlobeNewswire (USA) | ||
25.03. | Esperion Therapeutics, Inc.: Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & Industry Expert Theatre to be Presented at ACC.24 | 2 | GlobeNewswire (USA) |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 230 |
BAYER | 203 |
NEL | 194 |
NVIDIA | 167 |
TUI | 157 |
SIEMENS ENERGY | 155 |
RHEINMETALL | 144 |
PLUG POWER | 134 |
MERCEDES-BENZ | 130 |
BYD | 124 |
NOVAVAX | 117 |
TESLA | 105 |
DEUTSCHE BANK | 104 |
PALANTIR TECHNOLOGIES | 103 |
RWE | 98 |
BASF | 88 |
DEUTSCHE LUFTHANSA | 88 |
ALLIANZ | 86 |
VOLKSWAGEN | 82 |
COMMERZBANK | 70 |
THYSSENKRUPP | 70 |
AMAZON | 64 |
INFINEON | 62 |
E.ON | 60 |
SUPER MICRO COMPUTER | 60 |